02407nas a2200205   4500000000100000008004100001100001200042700001600054700001300070700001200083700001400095700001600109700001800125245013500143250001500278300000700293490000700300520184800307020004602155       2010                            d1 aJang J.1 aSchwarcz A.1 aAmaez D.1 aOlin J.1 aKeller M.1 aSchecter A.1 aWoodward Mark00aElevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross-sectional study  a2010/03/24  a120 v133 a<p>
BACKGROUND: Patients infected with HIV have an increased risk for accelerated atherosclerosis. Elevated levels of osteoprotegerin, an inflammatory cytokine receptor, have been associated with a high incidence of cardiovascular disease (including peripheral arterial disease, or PAD), acute coronary syndrome, and cardiovascular mortality. The objective of this study was to determine whether PAD is prevalent in an HIV-infected population, and to identify an association with HIV-specific and traditional cardiovascular risk factors, as well as levels of osteoprotegerin. METHODS: One hundred and two patients infected with HIV were recruited in a cross-sectional study. To identify the prevalence of PAD, ankle-brachial indices (ABIs) were measured. Four standard ABI categories were utilized: &lt; or = 0.90 (definite PAD); 0.91-0.99 (borderline); 1.00-1.30 (normal); and &gt;1.30 (high). Medical history and laboratory measurements were obtained to determine possible risk factors associated with PAD in HIV-infected patients. RESULTS: The prevalence of PAD (ABI &lt; or = 0.90) in a young HIV-infected population (mean age: 48 years) was 11%. Traditional cardiovascular risk factors, including advanced age and previous cardiovascular history, as well as elevated C-reactive protein levels, were associated with PAD. Compared with patients with normal ABIs, patients with high ABIs had significantly elevated levels of osteoprotegerin [1428.9 (713.1) pg/ml vs. 3088.6 (3565.9) pg/ml, respectively, p = 0.03]. CONCLUSIONS: There is a high prevalence of PAD in young HIV-infected patients. A number of traditional cardiovascular risk factors and increased osteoprotegerin concentrations are associated with abnormal ABIs. Thus, early screening and aggressive medical management for PAD may be warranted in HIV-infected patients.
</p>
  a1758-2652 (Electronic)1758-2652 (Linking)